The BICRHOME study was a prospective, multicenter study enrolling 312 cirrhotic patients with BSI. In this secondary analysis we selected patients receiving TZP or carbapenems as adequate empiric treatment. The 30-day mortality of patients receiving C/EI or intermittent infusion of TZP or carbapenems was assessed with Kaplan-Meier curves, Cox-regression model and estimation of the average treatment effect (ATE) using propensity score matching.
Extended infusion of β-lactams for bloodstream infection in patients with liver cirrhosis: an observational multicenter study / Bartoletti, Michele; Giannella, Maddalena; Lewis, Russell E; Caraceni, Paolo; Tedeschi, Sara; Paul, Mical; Schramm, Christoph; Bruns, Tony; Merli, Manuela; Cobos-Trigueros, Nazaret; Seminari, Elena; Retamar, Pilar; Muñoz, Patricia; Tumbarello, Mario; Burra, Patrizia; Cerenzia, Maria Torrani; Barsic, Bruno; Calbo, Ester; Maraolo, Alberto Enrico; Petrosillo, Nicola; Galan-Ladero, Maria Angeles; D'Offizi, Gianpiero; Zak-Doron, Yael; Rodriguez-Baño, Jesus; Baldassarre, Maurizio; Verucchi, Gabriella; Domenicali, Marco; Bernardi, Mauro; Viale, Pierluigi. - In: CLINICAL INFECTIOUS DISEASES. - ISSN 1058-4838. - ELETTRONICO. - 69:10(2019), pp. 1731-1739. [10.1093/cid/ciz032]
Extended infusion of β-lactams for bloodstream infection in patients with liver cirrhosis: an observational multicenter study
Bartoletti, Michele;Giannella, Maddalena;Lewis, Russell E;Caraceni, Paolo;Tedeschi, Sara;Baldassarre, Maurizio;Verucchi, Gabriella;Domenicali, Marco;Bernardi, Mauro;Viale, Pierluigi
2019
Abstract
The BICRHOME study was a prospective, multicenter study enrolling 312 cirrhotic patients with BSI. In this secondary analysis we selected patients receiving TZP or carbapenems as adequate empiric treatment. The 30-day mortality of patients receiving C/EI or intermittent infusion of TZP or carbapenems was assessed with Kaplan-Meier curves, Cox-regression model and estimation of the average treatment effect (ATE) using propensity score matching.| File | Dimensione | Formato | |
|---|---|---|---|
|
Bartoletti_2019.pdf
accesso aperto
Tipo:
Preprint
Licenza:
Licenza per Accesso Aperto. Altra tipologia di licenza compatibile con Open Access
Dimensione
1.24 MB
Formato
Adobe PDF
|
1.24 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
